Latest Regulatory News

PYC Therapeutics reported a narrowed half-year loss of $22.8 million while progressing four RNA drug candidates through clinical stages. The company announced a major $653 million capital raising to extend its cash runway to 2030 and support ongoing development.

Sequoia Financial Group reported a 75.9% jump in operating profit for 1H FY26 despite a net loss after non-operating charges, prompting a cautious dividend cut amid regulatory challenges.

BPM Minerals has responded to ASX scrutiny over the timing and materiality of its Bonnie & Clyde tenement grant announcement and related capital raising, confirming adherence to continuous disclosure rules.

Havilah Resources has secured a $31.5 million cash payment and $15 million in exploration funding from Sandfire Resources, accelerating plans for drilling and development around the Kalkaroo copper-gold deposit in South Australia.

Dragon Mountain Gold has responded to an ASX price query following a doubling of its share price, confirming no undisclosed information is driving the move and affirming compliance with listing rules.

Hydrocarbon Dynamics Limited (HCD) is set to transform its business by acquiring the Great Bear Copper-Gold-Silver-Uranium Project in Canada, backed by a $5.5 million capital raise and plans to re-list on the ASX under a new name.

Gryphon Capital Income Trust (ASX:GCI) has announced a $90.9 million wholesale placement of new units priced at $2.00 each, aiming to bolster its portfolio management capabilities. The placement leverages existing capacity, avoiding the need for unitholder approval.

ADX Energy has reported encouraging flow test results from its Welchau-1 well in Austria, confirming the presence of light oil and gas condensate in the Reifling Formation. The company plans further testing to unlock the reservoir’s full potential.

Lumos Diagnostics has hit a key enrollment milestone in its BARDA-funded paediatric study for FebriDx®, unlocking a US$720,000 payment and edging closer to FDA expansion.

Neurotech International has reported positive long-term safety results for its lead drug candidate NTI164, bolstering its path towards regulatory approval and chronic use in paediatric neurological disorders.

DigitalX Limited is launching a strategic investment program with up to A$30 million to diversify beyond Bitcoin accumulation, targeting profitable digital asset infrastructure businesses.

Close the Loop Limited reported a significant half-year loss driven by intangible asset impairments, yet underlying operations show promise with packaging sales up 18% and positive adjusted earnings.